PEGASUS TIMI54

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Stage
klaar
Medicine
ticagrelor
Population
ASCVD
Phase
III
First Patient In
15 November 2010
Last Patient In
-
Last Patient Last Visit
-

Study Director

dr. G.L. Bartels

Cardioloog

The page has expired.